Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
Zhu and Chen
Senge and Kurreck7b reported a one-step synthesis of
triptycene quinones by the reaction of anthracene and
excess quinones in acetic acid. Although some simple
pentiptycene quinones and their derivatives are known,13
there is not a practical and efficient method for the
synthesis of iptycene quinones until now. To a great
extent, it restricts the development of iptycene quinone
chemistry.
SCHEME 1
To develop novel receptors14 based on iptycene quino-
nes and their derivatives, iptycene quinones with unique
molecular cavities are required. Initially, we followed the
synthetic strategy of Senge and Kurreck to synthesize
iptycene quinones but found that it had some problems.
First, it consumed excess quinones so that it would be
impractical when the quinones were not easily obtained.
Second, complex results would be obtained if the excess
iptycene multiquinones were used. Moreover, the oxida-
tive capacity of the iptycene quinone is usually weaker
than that of the simple quinone, which has a direct effect
on the reactive result (low yield or only semiquinone
product obtained). Considering that excess quinones only
act as oxidants, we anticipated that p-chloranil, a com-
mercially available stronger oxidant, could be utilized
instead of the excess quinones in the one-pot method to
synthesize iptycene quinones. In this paper, we report a
practical and efficient method for the synthesis of ip-
tycene quinones, including a series of pentiptycene
quinones, heptiptycene quinones, and non-iptycene quino-
nes. Moreover, the structures of regioisomers were
determined by X-ray single-crystal structure analysis and
comparative reactions.
porphyrin and tetrathiafulvalene serving as donors, for
the synthesis of electron-transfer model compounds to
mimic the primary steps in photosynthesis7 and molec-
ular rectifiers.8 Recently, there is increasing attention in
the chemical and biological activities of triptycene quino-
nes.9 In particular, a number of triptycene quinones and
their derivatives were found to show potent anticancer
and antimalarial activities.9a,10
Iptycenes11 are extended triptycenes. They have at-
tracted considerable interest not only from their synthetic
challenge but also for their attractive rigid frameworks,
unique intramolecular cavities, and exceptional thermal
stability. Iptycene quinones9c,12 refer to derivatives of
iptycene bearing at least one triptycene quinone unit.
Pentiptycene monoquinones are a class of the most
simple iptycene quinones. Their derivatives were found
to be promising reagents for the preparation of fluores-
cent porous polymeric sensors for TNT,13a fluorescent
chemosensors for Cu2+ 13b
materials with monolayer
,
assembly structures,13c electron-donor porphyrin quinone
diads and triads,7b,c and building blocks for the construc-
tion of novel chain and channel networks.13d Compared
with triptycene quinones and iptycenes, still less is
known about iptycene quinones, especially complicated
ones.
Results and Discussion
Pentiptycene Quinones. Triptycene monoquinones
4
1a and 51b were prepared by the reactions of anthracene
1 and 1,4-dimethoxyanthracene 2 with excess p-benzo-
quinone in a one-pot approach, respectively. Bisquinone
61b was obtained by the oxidation of 5 with cerium (IV)
ammonium nitrate (CAN).15 Triptycene triquinone 71c
was synthesized by the reaction of 1,4,5,8-tetramethoxy-
anthracene 3 with excess p-benzoquinone in refluxing
acetic acid, followed by demethylation with hydriodic acid
and then oxidized by sodium bichromate in acetic acid.
Typically, triptycene quinones are synthesized by the
multistep method1 as shown in Scheme 1. Recently,
(7) (a) Wasielewski, M.; Niemczyk, M. P.; Johson, S. G.; Svec, W.
A.; Minsek, D. W. Tetrahedron 1989, 45, 4785-4806. (b) Wiehe, A.;
Senge, M. O.; Kurreck, H. Liebigs Ann. Recl. 1997, 1951-1963. (c)
Wiehe, A.; Senge, M. O.; Scha¨fer, A.; Speck, M.; Tannert, S.; Kurreck,
H.; Ro¨der, B. Tetrahedron 2001, 57, 10089-10110. (d) Springer, J.;
Kodis, G.; Garza, L.; Moore, A. L.; Moore, T. A.; Gust, D. J. Phys. Chem.
A 2003, 107, 3567-3575.
(8) Scheib, S.; Cava, M. P.; Baldwin, J. W.; Metzger, R. M. J. Org.
Chem. 1998, 63, 1198-1204.
(9) (a) Hua, D. H.; Tamura, M.; Huang, X.; Stephany, H. A.; Helfrich,
B. A.; Perchellet, E. M.; Sperfslage, B. J.; Perchellet, J.-P.; Jiang, S.;
Kyle, D. E.; Chiang, P. K. J. Org. Chem. 2002, 67, 2907-2912. (b)
Spyroudis, S.; Xanthopoulou, N. J. Org. Chem. 2002, 67, 4612-4614.
(c) Spyroudis, S.; Xanthopoulou, N. Tetrahedron Lett. 2003, 44, 3767-
3770.
(10) Perchellet, E. M.; Magill, M. J.; Huang, X.; Brantis, C. E.; Hua,
D. H.; Perchellet, J. P., Anti-Cancer Drugs 1999, 10, 749-766.
(11) (a) Hart, H.; Shamouilian, S.; Takehira, Y. J. Org. Chem. 1981,
46, 4427-4432. (b) Hart, H.; Bashir-Hashemi, A.; Luo, J.; Meador, M.
A. Tetrahedron 1986, 42, 1641-1654. (c) Hart, H. Pure Appl. Chem.
1993, 65, 27-34.
(12) (a) Williams, V. E.; Swager, T. M. Macromolecules 2000, 33,
4069-4073. (b) Lipczynska-Kochany, E.; Iwamura, H. Chem. Lett.
1982, 1075-1078.
(14) (a) Kla¨rner, F. G.; Benkhoff, J.; Boese, R.; Burkert, U.; Kamieth,
M.; Naatz, U. Angew. Chem. Int. Ed. Engl. 1996, 35, 1130-1133. (b)
Klarner, F. G.; Burkert, U.; Kamieth, M.; Boese, R.; Benet-Buchholz,
J. Chem.sEur. J. 1999, 5, 1700-1707. (c) Harmata, M.; Barnes, C.
L.; Karra, S. R.; Elahmad, S. J. Am. Chem. Soc. 1994, 116, 8392-
8393.
(13) (a) Yang, J. S.; Swager, T. M. J. Am. Chem. Soc. 1998, 120,
11864-11873. (b) Yang, J. S.; Lin, C. S.; Hwang, C. Y. Org. Lett. 2001,
3, 889-892. (c) Yang, J. S.; Lee, C. C.; Yau, S. L.; Chang, C. C.; Lee,
C. C.; Leu, J. M. J. Org. Chem. 2000, 65, 871-877. (d) Yang, J. S.;
Liu, C. P.; Lee, G. H. Tetrahedron Lett. 2000, 41, 7911-7915.
(15) Jacob, P., III; Callery, P. S.; Shulgin, A. T.; Castagoli, N. Jr. J.
Org. Chem. 1976, 41, 3627-3629.
918 J. Org. Chem., Vol. 70, No. 3, 2005